Sunday, October 11, 2026

Energy & Climate

2 articles

Bidgely Acquires Grid4C as Global AI Energy Market Races Toward $60.6B

US-based Bidgely acquired Israeli AI firm Grid4C in January 2025, combining grid analytics with consumer engagement into a single platform. The deal reflects mounting consolidation pressure in a market forecast to nearly triple from $22.82 billion in 2025 to $60.6 billion by 2030. Utilities worldwide are demanding fewer vendors and tighter data integration across their systems.

LM Salvado•Jun 14, 2026

Netherlands Delays Green Gas Mandate, Casting Shadow Over Europe's 2030 Biomethane Ambitions

The Netherlands has pushed back its mandatory green gas blending requirement to January 2027, raising fresh doubts about Europe's ability to scale biomethane production tenfold by 2030. The delay, cushioned by steeper initial targets, highlights a recurring tension across the energy transition: political commitment outpacing regulatory and industrial readiness. For global investors and policymakers watching Europe's green gas rollout, the Dutch stumble carries lessons well beyond its borders.

ViaNews Editorial Team•Feb 18, 2026

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave

Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,986

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,986 facts checked against source5,369 source documents archived

Query this data → isubstrate.com